Book cover of  Bad Blood by John Carreyrou — critical summary review on 12min

Bad Blood

John Carreyrou

5.0 (1 rating)
9 mins

In “Bad Blood,” John Carreyrou reveals the biggest corporate fraud that happened in Silicon Valley. Elizabeth Holmes, the CEO of this highly controversial biotech startup, Theranos - tasked to make blood testing cheap and accessible was exposed by Carreyrou who found out that Theranos’ technology was far off from its initial goal, which was to perform tests for more than 240 different ailments.

Listen to the intro

Who it is for

Best suited for anyone interested in a one-sitting reading, crime thriller from the Silicon Valley.

Key Insights

The Cult of Personality

One of the most striking insights from 'Bad Blood' is how Elizabeth Holmes's charisma and vision managed to captivate investors, board members, and the media, creating a cult of personality around her leadership. Holmes, with her deep voice and Steve Jobs-inspired wardrobe, portrayed herself as a visionary leader in the healthcare industry. This carefully crafted persona was instrumental in obtaining immense financial backing and support, despite the lack of a viable product. Her ability to inspire and convince people of her mission highlights the powerful role of personality in business, which can sometimes overshadow objective due diligence and critical analysis.

The Danger of Unchecked Ambition

The story of Theranos serves as a cautionary tale about the dangers of unchecked ambition in the startup world. Holmes's vision to revolutionize blood testing was ambitious and potentially transformative. However, this ambition quickly turned toxic as it outpaced the actual technological capabilities of the company. The relentless pursuit of this vision, without aligning it with scientific reality, led to ethical compromises and outright deception. This insight underscores the importance of balancing ambition with responsibility and transparency, especially in industries where public health and safety are at stake.

Corporate Governance Failures

Theranos's downfall also highlights significant failures in corporate governance. The company was able to operate with minimal oversight from its board of directors, many of whom lacked the necessary expertise in biotechnology to adequately assess the company's progress and claims. This lack of critical oversight allowed Holmes to maintain control and continue misleading stakeholders. The case underscores the vital role that a knowledgeable and engaged board of directors plays in safeguarding against misconduct and ensuring that a company's operations are aligned with ethical and legal standards.

Login

Login to your account

Enter your credentials to access your account

Don't have an account? Sign up

About the Author

John Carreyrou is a French American journalist. He is most popular for exposing the one-time multibillion-dollar biotech startup Theranos. He was awarded the Gerald Loeb Award for Distinguished Business and Financial Journalism in the category of beat reporting, the George Polk Award for Financial Reporting, and the Barlett & Steele Silver Award for Investigative Business Journalism. He won the Pulitzer Prize twice. Nowadays, he works as an editor at Bloomberg News.

View author profile

Lessons

  • How a Stanford dropout became the wealthiest self-made female billionaire in the US before she reached 30.
  • Why her net worth was revised to zero dollars just after her 31st birthday.
  • Why the braggadocio-based fake-it-until-you-make-it mindset of the Silicon Valley can be just as dangerous as a global war.

Key Takeaways

  • Be skeptical of too-good-to-be-true claims: The story of Theranos highlights the importance of critically evaluating bold promises, especially in the tech and biotech fields where new innovations are often overhyped.
  • Due diligence is crucial: Investors and partners must conduct thorough research and verification of any company's technology and claims before committing resources.
  • Transparency and accountability are non-negotiable: Companies must maintain honest communication and clear accountability to ensure trust and prevent fraudulent practices.

More knowledge in less time

Listen to the key ideas

We offer various commission schemes from one-time payouts.

Find your next read

12Min is very popular among readers and lifelong learners.

Good Micropaths

12Min's browser-based app works for anyone.

Frequently asked

Frequently Asked Questions

Everything you need to know about 12min

In the 12min App, we extract the best ideas and insights from the world's best-selling non-fiction books and organize them into unique, self-contained narrative summaries that can be consumed in audio and/or text in about 12 minutes!

You can download our app and start enjoying our library. If for any reason you are not satisfied with our platform, simply contact our support team ([email protected]) within 7 days of purchase and request a refund. You will receive everything you paid for, without questions or bureaucracy.

Yes, but the change will only apply from the next billing period. For example, if you decide to change your monthly subscription to an annual one, after confirming the change to the annual plan, the new plan will only be applied and charged after that month's billing anniversary.

12min Premium is a plan that guarantees you access to our entire library of 2500+ titles available in 3 languages (English, Spanish, and Portuguese) that you can read or listen to at any time through our app available for iOS, Android, and Computer. You can also read or listen to your favorite titles offline and challenge yourself with a quiz to help you retain the content at the end of each microbook.

Yes, if you decide not to renew your 12min subscription, you can cancel at any time and the next billing cycle will not occur.

Feel free to contact us at [email protected].